​

Cronos Group (CRON) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CRON Stock Forecast

Cronos Group (CRON) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $2.30, with a high of $2.30 and a low of $2.30. This represents a 13.86% increase from the last price of $2.02.

High: $2.3 Avg: $2.3 Low: $2.3 Last Closed Price: $2.02

CRON Stock Rating

Cronos Group stock's rating consensus is Hold, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (25.00%), 2 Hold (50.00%), 1 Sell (25.00%), and 0 Strong Sell (0.00%).

Hold
Total 4 0 1 2 1 Strong Sell Sell Hold Buy Strong Buy

CRON Price Target Upside V Benchmarks

TypeNameUpside
StockCronos Group13.86%
SectorHealthcare Stocks 23.08%
IndustrySpecialty & Generic Drug Manufacturers Stocks27.57%
IdeaCannabis Stocks List120.66%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$2.30
Last Closing Price$2.02$2.02$2.02
Upside/Downside--13.86%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 25112-15
Jan, 25112-15
Dec, 24113-16
Nov, 24113-16
Oct, 24113117
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 09, 2024Lisa LewandowskiBank of America Securities$2.30$2.32-0.86%13.86%
Sep 30, 2022Barclays$3.50$2.9319.45%73.27%
May 11, 2022Matt BottomleyCanaccord Genuity$4.50$3.1841.51%122.77%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 09, 2024Bank of America SecuritiesUnderperformUnderperformhold
May 15, 2024CIBCOutperformOutperformhold
Apr 08, 2024Bank of America SecuritiesUnderperformUnderperformhold
Sep 30, 2022BarclaysEqual-WeightEqual-Weighthold
Feb 22, 2022Canaccord GenuitySellSellhold
Feb 22, 2022Piper SandlerNeutralNeutralhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-0.21$-1.07$-0.45$-0.19----
Avg Forecast$0.04$-0.35$-0.36$-0.15$-0.09$0.04$0.12$0.06
High Forecast$0.03$-0.37$-0.38$-0.16$-0.09$0.04$0.11$0.05
Low Forecast$0.04$-0.32$-0.33$-0.15$-0.09$0.04$0.12$0.06
Surprise %-625.00%205.71%25.00%26.67%----

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$46.72M$74.44M$91.90M$120.27M----
Avg Forecast$43.79M$71.57M$94.11M$88.75M$122.03M$144.75M$147.27M$162.00M
High Forecast$41.29M$67.48M$88.42M$88.00M$116.13M$137.75M$147.24M$161.96M
Low Forecast$45.59M$74.51M$97.48M$89.50M$125.29M$148.62M$147.31M$162.04M
Surprise %6.69%4.01%-2.35%35.51%----

Net Income Forecast

$-1B $-600M $-200M $200M $600M $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-74.62M$-396.70M$-168.73M$-73.96M----
Avg Forecast$234.45M$-133.50M$32.30M$-69.85M$-34.21M$16.25M$43.41M$21.71M
High Forecast$-92.34M$-140.64M$-122.55M$-862.93M$-35.90M$15.44M$41.26M$20.63M
Low Forecast$561.24M$-123.59M$187.15M$723.23M$-32.52M$17.05M$45.56M$22.78M
Surprise %-131.83%197.16%-622.41%5.89%----

CRON Forecast FAQ

Is Cronos Group stock a buy?

Cronos Group stock has a consensus rating of Hold, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Cronos Group is a neutral investment for most analysts.

What is Cronos Group's price target?

Cronos Group's price target, set by 4 Wall Street analysts, averages $2.3 over the next 12 months. The price target range spans from $2.3 at the low end to $2.3 at the high end, suggesting a potential 13.86% change from the previous closing price of $2.02.

How does Cronos Group stock forecast compare to its benchmarks?

Cronos Group's stock forecast shows a 13.86% upside, underperforming the average forecast for the healthcare stocks sector (23.08%) and underperforming the specialty & generic drug manufacturers stocks industry (27.57%), trailing the Cannabis Stocks List (120.66%) investment idea.

What is the breakdown of analyst ratings for Cronos Group over the past three months?

  • February 2025: 20.00% Strong Buy, 20.00% Buy, 40.00% Hold, 0% Sell, 20.00% Strong Sell.
  • January 2025: 20.00% Strong Buy, 20.00% Buy, 40.00% Hold, 0% Sell, 20.00% Strong Sell.
  • December 2024: 16.67% Strong Buy, 16.67% Buy, 50.00% Hold, 0% Sell, 16.67% Strong Sell.

What is Cronos Group’s EPS forecast?

Cronos Group's average annual EPS forecast for its fiscal year ending in December is $-0.09 for 2024, a -52.63% decrease from the reported $-0.19 in 2023. The prediction for 2025 is $0.04, $0.12 for 2026, and $0.06 for 2027.

What is Cronos Group’s revenue forecast?

Cronos Group's average annual revenue forecast for its fiscal year ending in December is $122.03M for 2024, a 1.46% increase from the reported $120.27M in 2023. The forecast for 2025 is $144.75M, $147.27M for 2026, and $162M for 2027.

What is Cronos Group’s net income forecast?

For its fiscal year ending in December, Cronos Group's average annual net income forecast is $-34.209M for 2024, reflecting a -53.75% decrease from the reported $-73.963M in 2023. The projection for 2025 is $16.25M, $43.41M for 2026, and $21.71M for 2027.